Our study showed that the level of baseline FGF23 level was higher in those patients with diabetic nephropathy (P = 0.012), however no difference in the level of this marker between those with and without nephropathy 3 and 12 months after initial assessment. The gene discussed is FGF23; the disease is kidney disorder.